An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
Phase of Trial: Phase IV
Latest Information Update: 02 Dec 2015
At a glance
- Drugs Bimatoprost (Primary) ; Hypromellose; Timolol; Travoprost
- Indications Glaucoma; Ocular hypertension
- Focus Therapeutic Use
- Sponsors Allergan
- 07 Jun 2017 Biomarkers information updated
- 16 Apr 2015 Status changed from active, no longer recruiting to completed, according to to ClinicalTrials.gov record.
- 27 Aug 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.